CSIMarket Company Name, Ticker, Customers, else..
 
Aeon Biopharma inc   (AEON)
Other Ticker:  
 
 

Aeon Biopharma Inc Cash flow Statement Quarterly

AEON



Select the Financial Report:   Period:   Fiscal Year:



Cash flow Statement
(Quarterly, GAAP in millions $)

(Sep 30 2024)
9 Months 		(Mar 31 2024)
3 Months 		(Dec 31 2023)
12 Months		 (Sep 30 2023)
9 Months 		(Jun 30 2023)
6 Months
Income 39.92 -118.02 -323.95 -17.99 -4.33
Depreciation & amortization 0.07 0.03 0.05 0.04 -
Amortization of Other Assets - - - - -
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense - - - - -
Restructuring & Impairment Charges - - - - -
Provision for Loan, Lease, and Other Losses - - - - -
Inventories Decrease /-Increase - - - - -
R & D, Environmental and Other Expense - - - - -
Gain (Loss) on Disposition of Assets - - - - -
Share-based Compensation 4.91 1.62 3.77 4.22 -
Income (Loss) from Equity Method Investments - - - - -
Fair Value Adjustment of Warrants 15.38 20.90 -2.32 - 0.67
Interest Earned On Cash Held In Trust Account - - - -1.90 -1.70
Transaction Costs Other - - - - -
Gain On Forgiveness Of Deferred Underwriting Fee Payable - - - -0.20 -0.20
Increase Decrease Income And Franchise Tax Payable - - - 0.55 0.80
Write Off Of Deferred Debt Issuance Cost - - 0.33 -0.59 -0.59
Change In Fair Value Of Convertible Notes 0.17 0.09 -15.26 - -
Change In Fair Value Of Forward Purchase Agreement And Derivative 19.93 22.92 - - -
Change In Amount Of Contingent Consideration Liability -97.46 63.77 - - -
Increase Decrease In Accrued Expenses And Other Liabilities -3.18 -3.23 0.28 - -
Increase Decrease In Accrued Expenses And Other Liabilities - - 0.28 - -
Income taxes - - - - -
Losses/ -gains on Investments net - - - - -
Accounts Receivable - - - - -
Increase (Decrease) in Accounts Payable 1.24 3.14 -4.34 1.43 -
Accrued Expense - - - - 4.34
Deferred Revenue and Customer Advances and Deposits - - - - -
Increase (Decrease) in Prepaid Expense and Other Assets -0.77 0.12 -0.69 -0.02 -0.11
Other Working Capital 0.12 0.06 0.00 -0.17 -
Other Noncash Items - - - - -
Other net - - - - -
Payments for (Proceeds from) Other Operating Activities 0.00 0.00 348.00 -0.28 -
Discontinued operations - - - - -
Net Cash flow from Operating Activities -19.67 -8.60 -26.08 -27.13 -1.57
Capital Expenditures - - - -0.30 -
Sale of Capital Items - - - - -
Short-term Investments Proceeds - - - - -0.40
Short-term Investments Acq. - - - - -
Real Estate Investments - - - - -
Payment To Acquire Investments - - - - -
Withdrawal From Trust To Acquire Investments - - - - -
Withdrawal From Trust Account For Tax Obligations - - - 1.49 1.25
Cash Withdrawn For Redemptions - - - 259.00 259.00
Restricted Cash and Investments Increase (Decrease) - - - - -
Payments for (Proceeds from) Loans - - - - -
Payments for (Proceeds from) Deposits - - - - -
Payments for (Proceeds from) Other Investments - - - - -
Payments for (Proceeds from) Federal Reserve and Federal Home Loan Bank - - - - -
Acquisition Net of Cash Acquired - - - - -
Interest in Subsidiaries and Affiliates - - - - -
Sale of businesses - - - - -
Accounts payable - - - - -
Receivables - - - - -
Payments for (Proceeds from) Other Investing Activities - - - - -
Other Net - - - - -
Discontinued operations - - - - -
Net Cash flow from Investing Activities - - - -0.30 260.09
Short-term debt Net - - - - 1.00
Other borrowing transactions - - - - -
Long-term debt - borrowings 15.00 5.00 - 44.50 -
Long-term debt - repayments - - - - -0.15
Federal Home Loan Bank and Federal Funds - - - - -
Issuances/ -repurchases of Comm. Stock 0.05 - - - -
Partnership and Parent Transactions - - - - -
Issuances/ -repurchases of Pref. Stock - - - - -
Deposits, Annuities, Contract Holders Funds - - - - -
Other financing activities net - - - - -
Other net - - - - -
Net Proceeds From Initial Public Offering - - - - -
Proceeds From Working Capital Loans - - - - -
Proceeds From Working Capital Loan - - - - -
Payments For Redemption Of Temporary Equity - - - -259.00 -259.00
Payments of Dividends, Preferred Stock and Preference Stock - - - - -
Dividends paid - - - - -
Net Cash flow from Financing Activities 15.05 5.00 - 44.50 -258.15
Effect of exchange rate on cash flow - - - - -
Discontinued operations - - - - -
Free Cash Flow -19.67 -8.60 -26.08 -27.43 -1.57
Total Cash Flow -4.62 -3.60 -26.08 17.07 0.37




Untitled Document 





	
			
  

 







  

	  


 
    Help


	About us


	Advertise




			

  




CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  
    Copyright © 2024 CSIMarket, Inc. All rights
  reserved. 



Intraday data delayed per exchange requirements.  All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com